Imatinib Mesilate (Imatinib Mesylate) contains not less than 98.0% and not more than 102.0% of C30H35N7SO4, calculated on the anhydrous substance.

共有 1 個藥物證書使用此成份

抑嘧啶挺命甲磺酸鹽
Imatinib Mesylate

• 申請商: 日名國際藥品有限公司
• 適應症: 白血病用藥
• 發證日期: 2021-08-20